project,environment,SUBJECT_ID,Instance,CM_ID,CM_TREATMENT,CM_INDICATION,CM_STDATE,CM_ONGOING,CM_ENDATE,CM_DOSE,CM_UNIT,CM_ROUTE,CM_DOSFRQ
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,1,CANDESARTAN,HYPERTENSION,01Feb2000:00:00:00.000,N,19AUG2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,2,ALLOPURINOL,SKIN RASH,01Feb2000:00:00:00.000,Y,.,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,4,AZITHROMYCIN,INDICATION 1,01JAN2019:00:00:00.000,N,21JUL2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,5,BROTIZOLAM,INDICATION 2,01JAN2019:00:00:00.000,N,21JUL2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,6,ESZOPICLONE,INSOMNIA,24JUN2022:00:00:00.000,N,10DEC2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,7,METFORMIN,DIABETES,01JAN2019:00:00:00.000,Y,.,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,8,ESOMEPRAZOLE,INDICATION 2,01JAN2019:00:00:00.000,Y,.,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,9,PARENTERAL NUTRITION,SUPPLEMENTARY,01JAN2019:00:00:00.000,N,21JUL2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,10,CLOBETASOL,ERYTHEMA,15JUL2022:00:00:00.000,N,19JUL2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,11,TYLENOL,PAIN,15JUL2022:00:00:00.000,N,19JUL2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,13,PREDNISOLONE,INDICATION 2,20JUL2022:00:00:00.000,N,21JUL2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,14,PATASSIUM,MELAENA,21JUL2022:00:00:00.000,N,04AUG2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,15,PREDNISOLONE,ERYTHEMA,22JUL2022:00:00:00.000,N,23JUL2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,17,HALOPERIDOL,INDICATION 1,21JUL2022:00:00:00.000,N,23JUL2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,18,EPINEPHRINE,INDICATION 2,24JUL2022:00:00:00.000,N,24JUL2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,19,HYDROXYZINE,INSOMNIA,25JUL2022:00:00:00.000,N,06AUG2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,20,Q1,INDICATION 1,27JUL2022:00:00:00.000,N,04AUG2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,21,MOVIPREP,INDICATION 1,28JUL2022:00:00:00.000,N,28JUL2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,24,RED BLOOD CELLS,INDICATION 3,24JUL2022:00:00:00.000,N,24JUL2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,28,GLUCAGON,GI FIBERSCOPY,02AUG2022:00:00:00.000,N,02AUG2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,29,RED BLOOD CELLS,INDICATION 3,21JUL2022:00:00:00.000,N,21JUL2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,30,DEXAMETHASONE,INDICATION 4,18JUL2022:00:00:00.000,N,18JUL2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,31,CANDESARTAN ,HYPERTENSION,20AUG2022:00:00:00.000,N,10SEP2022:00:00:00.000,100,mg ,PO ,QD 
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,32,PARENTERAL NUTRITION,SUPPLEMENTARY ,20AUG2022:00:00:00.000,Y,.,100,mg ,PO ,PRN
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,33,DEXAMETHASONE,PREMEDICATION,01JUL2022:00:00:00.000,N,21OCT2022:00:00:00.000,100,mg ,PO ,PRN
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,34,FAMOTIDINE,INDICATION 1,01JUL2022:00:00:00.000,N,21DEC2022:00:00:00.000,100,mg ,PO ,PRN
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,35,FLUNITRAZEPAM,INSOMNIA,20AUG2022:00:00:00.000,N,07NOV2022:00:00:00.000,100,mL,PO ,PRN
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,36,BROTIZOLAM,INDICATION 1,20AUG2022:00:00:00.000,N,07NOV2022:00:00:00.000,100,mL,PO ,PRN
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,37,CANDESARTAN,HYPERTENSION,11SEP2022:00:00:00.000,N,04OCT2022:00:00:00.000,100,mL,PO ,PRN
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,38,SUPPLEMENT1,PREVENTION,24SEP2022:00:00:00.000,Y,.,100,mL,PO ,PRN
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,39,MAGNESIUM ,PREVENTION,24SEP2022:00:00:00.000,Y,.,100,mL,PO ,PRN
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,40,COVID-19  VACCINE,COVID-19,09OCT2022:00:00:00.000,N,09OCT2022:00:00:00.000,100,mL,PO ,PRN
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,42,OLANZAPINE,HEADACH,22OCT2022:00:00:00.000,N,24DEC2022:00:00:00.000,100,mL,PO ,PRN
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,43,METOCLOPRAMIDE,INDICATION 1,15JUL2022:00:00:00.000,Y,.,100,mL,PO ,PRN
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,44,ALPROSTADIL,SKIN RASH,19NOV2022:00:00:00.000,N,24DEC2022:00:00:00.000,100,mL,PO ,PRN
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,45,CANDESARTAN ,HYPERTENSION,26FEB2023:00:00:00.000,Y,.,100,mL,PO ,PRN
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,46,MIROGABALIN ,HEADACH,18MAR2023:00:00:00.000,Y,.,100,mL,PO ,PRN
NS_icsr_auto,NS_Demo,100-001,Concomitant Medication,47,METFORMIN,INDICATION 1,15MAR2023:00:00:00.000,Y,.,100,mL,PO ,PRN
